PDE4B inhibition by nerandomilast: Effects on lung fibrosis and transcriptome in fibrotic rats and on biomarkers in human lung epithelial cells

Documenti analoghi

• Familial pulmonary fibrosis: Defining inherited fibrotic lung disease in the era of clinical genetic testing
  di: Joanne L. Dickinson, et al.
  Pubblicazione: (2024)
• JAM2 is a prognostic biomarker and inhibits proliferation, metastasis and epithelial–mesenchymal transition in lung adenocarcinoma
  di: Yanxin Dong, et al.
  Pubblicazione: (2024)
• Steroid therapy in acute exacerbation of fibrotic interstitial lung disease
  di: Kavya Koshy, et al.
  Pubblicazione: (2024)
• Clu + transitional alveolar epithelial cells promote lung injury repair and fibrosis progression
  di: Yuquan Wang, et al.
  Pubblicazione: (2026)
• Type‐II IFN inhibits SARS‐CoV‐2 replication in human lung epithelial cells and ex vivo human lung tissues through indoleamine 2,3‐dioxygenase‐mediated pathways
  di: Dong Yang, et al.
  Pubblicazione: (2024)